Concepedia

R.F. Salgado

RS

Statistics

Publications

1

Citations

27

H-Index

1

Active since

2022

Affiliations

The Netherlands Cancer Institute(Current)

R.F. Salgado is an author at The Netherlands Cancer Institute specializing in triple-negative breast cancer therapy, cd4+ tumor-infiltrating lymphocytes, and cancer immunology.

Publications per year

2022–2022

1

Publications

1

LBA13 Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial

I. Nederlof, Olga I. Isaeva, N. Bakker et al. · Annals of Oncology · 2022 · 27 citations

Medicine, Immunology, Oncology +17

1–1 of 1